SCHEMBL5810367

SCHEMBL5810367

Cc1cnc(NC2C3CC4CC(C3)CC2C4)s1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
EPHX2 P34913 2/20 0.46
SMN1; SMN2 Q16637 4/20 0.42
RAB9A P51151 5/20 0.38
NPC1 O15118 3/20 0.38
GAA P10253 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GABBR2 O75899 1/20 0.38
GABBR1 Q9UBS5 1/20 0.38
KDR P35968 1/20 0.37
FDPS P14324 1/20 0.37
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.35
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1074920 0.80 ALDH1A1 (0.42) ALDH1A1HTTHSD17B10EPHX2SMN1; SMN2
SCHEMBL1075154 0.80 CDK2 (0.44) ALDH1A1HTTHSD17B10EPHX2SMN1; SMN2
SCHEMBL3709518 0.69 HTT (0.53) ALDH1A1HTTHSD17B10EPHX2SMN1; SMN2
SCHEMBL964051 0.67 SMN1; SMN2 (0.63) ALDH1A1HTTEPHX2SMN1; SMN2RAB9A
SCHEMBL964050 0.67 SMN1; SMN2 (0.63) ALDH1A1HTTEPHX2SMN1; SMN2RAB9A
SCHEMBL903169 0.65
SCHEMBL2642559 0.64
SCHEMBL18469877 0.64
SCHEMBL19798426 0.64 CNR1 (0.51) ALDH1A1HTTHSD17B10EPHX2SMN1; SMN2
SCHEMBL1332997 0.63 ALDH1A1 (1.00) ALDH1A1HTTHSD17B10EPHX2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006119295-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES COMBINATORX, INCORPORATED (US) 2006-11-09 WO disclosed